Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVS
12976
CALL
VivoSim Labs
VIVS
$1.13M
| $13K | ﹤0.01% |
642
-425
| -40% | -$9.59K |
|
12977
Taoping
TAOP
$8.12M
| $13K | ﹤0.01% |
+65
| New | +$13.2K |
|
|
EARN
12978
PUT
Ellington Residential Mortgage REIT
EARN
$165M
| $13K | ﹤0.01% |
1,800
-3,000
| -63% | -$21.3K |
|
12979
CALL
iBio
IBIO
$71M
| $12.9K | ﹤0.01% |
1,061
+865
| +441% | +$16.3K |
|
12980
Evogene
EVGN
$9.49M
| $12.9K | ﹤0.01% |
1,210
-4,483
| -79% | -$30.3K |
|
|
PFC
12981
CALL
DELISTED
Premier Financial Corp. Common Stock
PFC
| $12.8K | ﹤0.01% |
800
-1,300
| -62% | -$21.4K |
|
12982
Ericsson
ERIC
$33.6B
| $12.8K | ﹤0.01% |
2,350
-138,906
| -98% | -$745K |
|
12983
PUT
VanEck Steel ETF
SLX
$173M
| $12.8K | ﹤0.01% |
200
-2,300
| -92% | -$140K |
|
12984
CALL
CTS Corp
CTS
$1.81B
| $12.8K | ﹤0.01% |
300
-1,100
| -79% | -$48.3K |
|
|
TERN
12985
DELISTED
Terns Pharmaceuticals
TERN
| $12.7K | ﹤0.01% |
1,456
-390,609
| -100% | -$4.55M |
|
12986
PUT
SCYNEXIS
SCYX
$51.5M
| $12.7K | ﹤0.01% |
538
-3,375
| -86% | -$78.8K |
|
|
NUVL
12987
CALL
DELISTED
Nuvalent
NUVL
| $12.7K | ﹤0.01% |
300
-10,100
| -97% | -$382K |
|
12988
CALL
Montauk Renewables
MNTK
$268M
| $12.6K | ﹤0.01% |
1,700
+1,000
| +143% | +$6.89K |
|
|
YGMZ
12989
DELISTED
MingZhu Logistics Holdings
YGMZ
| $12.6K | ﹤0.01% |
113
-269
| -70% | -$38.3K |
|
12990
PUT
Dr. Reddy's Laboratories
RDY
$10.2B
| $12.6K | ﹤0.01% |
1,000
-5,000
| -83% | -$58.4K |
|
|
PPBT
12991
CALL
Purple Biotech
PPBT
$2.44M
| $12.6K | ﹤0.01% |
45
-138
| -75% | -$49.5K |
|
12992
CALL
PharmaCyte Biotech
PMCB
$5.92M
| $12.6K | ﹤0.01% |
4,400
+1,000
| +29% | +$3K |
|
12993
CALL
1st Source
SRCE
$2.13B
| $12.6K | ﹤0.01% |
300
-1,300
| -81% | -$55.9K |
|
12994
CALL
SEACOR Marine Holdings
SMHI
$268M
| $12.6K | ﹤0.01% |
1,100
-300
| -21% | -$2.65K |
|
12995
CALL
Vivani Medical
VANI
$126M
| $12.6K | ﹤0.01% |
+10,389
| New | +$12.8K |
|
|
DMYY.WS
12996
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
| $12.6K | ﹤0.01% |
80,811
+36,956
| +84% | +$6.78K |
|
12997
PUT
Invesco Leisure and Entertainment ETF
PEJ
$314M
| $12.5K | ﹤0.01% |
+300
| New | +$12.2K |
|
12998
CALL
Culp Inc
CULP
$42.1M
| $12.4K | ﹤0.01% |
2,500
+900
| +56% | +$4.51K |
|
12999
CALL
Dogness International Corp
DOGZ
$16.8M
| $12.4K | ﹤0.01% |
825
+775
| +1,550% | +$12.3K |
|
|
PPBI
13000
CALL
DELISTED
Pacific Premier Bancorp
PPBI
| $12.4K | ﹤0.01% |
600
-100
| -14% | -$2.08K |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.